Found 17 articles for: "Trial"
Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review
April 2026 | Volume 25 | Issue 4 | Original Article | 316 | Copyright © April 2026
Background: Janus kinase (JAK) inhibitors represent promising therapies for dermatologic conditions, including psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), s...
Read MoreRacial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome
February 2026 | Volume 25 | Issue 2 | Original Article | 159 | Copyright © February 2026
Background: Racial disparities in clinical trial enrollment can limit the generalizability of therapeutic data, which is particularly damaging for conditions that disproportionat...
Read MoreDisparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024
December 2025 | Volume 24 | Issue 12 | Original Article | 1203 | Copyright © December 2025
Background: There is a notable lack of diversity in dermatologic studies, even concerning conditions that are known to have a higher prevalence in the skin of color (SOC) populat...
Read MoreCaffeine Supplementation and Hair: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1070 | Copyright © November 2025
Background: While caffeine has been proposed to stimulate hair growth, its safety and efficacy remain unclear. This systematic review evaluates the effects of caffeine interventi...
Read MoreThe Current Landscape of Vitiligo Treatment Centers
August 2025 | Volume 24 | Issue 8 | Editorials | e51 | Copyright © August 2025
Clinical Profile of Halobetasol Propionate 0.01%/ Tazarotene 0.045% Lotion in Patients With Hyperkeratotic Plaque Psoriasis
June 2025 | Volume 24 | Issue 6 | Original Article | 590 | Copyright © June 2025
Background: Hyperkeratotic psoriatic plaques, characterized by considerable elevation and scaling, present treatment challenges with topical therapy. This post hoc analysis of tw...
Read MoreRapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis
June 2025 | Volume 24 | Issue 6 | Original Article | 600 | Copyright © June 2025
Background: In the ADORING 1 and 2 phase 3 trials, tapinarof cream 1% once daily (QD) demonstrated significant efficacy and was well tolerated in adults and children down to 2 ye...
Read MoreTreatment of Acne-Induced Macular Hyperpigmentation in Fitzpatrick Skin Types V - VI: A Scoping Review
June 2025 | Volume 24 | Issue 6 | Original Article | 579 | Copyright © June 2025
Acne-induced macular hyperpigmentation (AMH) is a common issue among patients with highly melanated skin, particularly those with Fitzpatrick Skin Types (FST) V - VI, which includes nonwhite pati...
Read MoreClinical Utility of TRPV1 Modulation for Skincare Sensitivity
April 2025 | Volume 24 | Issue 4 | Original Article | 366 | Copyright © April 2025
The Transient Receptor Potential Vanilloid 1 (TRPV1) protein, originally recognized for its role in modulating peripheral sensory neurons and transmitting pain and itch signals, has been increasi...
Read MoreRacial and Ethnic Representation in Atopic Dermatitis Clinical Trials
April 2025 | Volume 24 | Issue 4 | Original Article | 360 | Copyright © April 2025
Read MoreDupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups
February 2025 | Volume 24 | Issue 2 | Original Article | 167 | Copyright © February 2025
Background: Lichenification, common in moderate to severe atopic dermatitis (AD) at any age, is often difficult to treat. This analysis assessed dupilumab vs placebo in AD lichen...
Read MoreNon-Surgical Correction of Dermatochalasis Using Microplasma
February 2025 | Volume 24 | Issue 2 | Original Article | 134 | Copyright © February 2025
Background: Dermatochalasis is characterized by the presence of redundant and loose upper eyelid skin, which occurs as part of the aging process and is often considered aest...
Read MoreUse of Upadacitinib in Refractory Behcet's Disease: Case Report and Systematic Literature Review
February 2025 | Volume 24 | Issue 2 | Case Reports | e1 | Copyright © February 2025
IL-36 Trials in Dermatology: Cross-Sectional Analysis of ClinicalTrials.gov-Registered Trials
December 2024 | Volume 23 | Issue 12 | Editorials | e195 | Copyright © December 2024
A Multi-Center, Double-Blind, Randomized, Comparator Controlled Trial Evaluating Topical Formulations for Skin Fragility of the Arms
December 2024 | Volume 23 | Issue 12 | Original Article | 1064 | Copyright © December 2024
Background: Skin atrophy and fragility associated with Dermatoporosis result from chronic extracellular matrix (ECM) degradation. A current marketed product, ReFORM & RePAIR ...
Read MoreSkin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022
March 2023 | Volume 22 | Issue 3 | Features | 310 | Copyright © March 2023
There is a plethora of dermatologic clinical trials; however, little is known regarding the representation of skin of color (SOC) populations. We evaluated the 15 most prevalent skin conditions in SOC...
Read MoreAssessing Participant Diversity in Acne Clinical Trials
July 2022 | Volume 21 | Issue 7 | Editorials | 797 | Copyright © July 2022
A lack of clinical trials devoted specifically to treatment protocols in minority groups and diverse individuals with skin of color (SOC) exists. Treatment decisions often vary based on patient cultur...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
